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Abstract 
The adsorption of macrocyclic antibiotic eremomycin on the capillary wall has been studied and concentration of EOF reversion 
has been determined. The combination of coupled chitosan coating and macrocyclic antibiotic as run buffer additive has been 
proposed for chiral separation. The advantages (time analysis and efficiency) of coupled chitosan-coated capillary over fused-
silica capillary have been shown. The effect of experimental parameters, influencing the enantioseparation, has been investigated. 
Carboxylic acids bearing α-C*-asymmetric carbon atom (ibuprofen, indoprofen, ketoprofen, fenoprofen, flurbiprofen, mandelic, 
3-phenylbutiric, 2-phenoxypropionic, and α-methoxyphenylacetic acids) have been enantioseparated with the separation 
selectivity being more than 1.04. The analysis time was less than 9 minutes.  
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1. Introduction 
Enantioseparations of non-steroidal anti-inflammatory drugs were achieved using different types of chiral 
selectors (cyclodextrins, antibiotics, proteins etc.) [1]. Macrocyclic antibiotics are ones of the most promising chiral 
selectors, used in capillary electrophoresis (CE) [2]. Many ionizable groups and chiral centers provide successful 
separations of different types of enantiomers, especially the ones, containing carboxylic groups. Vancomycin, 
teicoplanin are most widely used [3,4]. In our previous works, the efficient separation of profens using eremomycin 
as a chiral selector was demonstrated [5]. A common disadvantage of the macrocyclic glycopeptide antibiotics is the 
adsorption of the selector on the uncoated capillaries (at pH < pI). This selector-wall interaction leads to the 
elongation of the analysis time and reduction of the separation efficiency. To overcome this problem, using run 
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 buffer with relatively high ionic strength (0.05-0.1 M) or SDS-containing buffer was proposed [6,7]. Unfortunately, 
in this case, high conductivity of buffer limits the applicable voltage; and because of the increase in heat generation, 
the decomposition of antibiotic can occur [8]. Therefore, the use of the coated capillaries is particularly 
advantageous for reducing the adsorption phenomenon. Different types of coating were suggested: covalently 
bonded polyacrilamide [9], poly(dimethylacrilamide) [10], physically adsorbed coating (HDB [11], chitosan [12]) . 
Huang, B. et al. [13] reported a simple and stable chitosan-based coating, so called coupled chitosan coating, which 
could be used in a wide range of pH. It was prepared by absorbing chitosan to the wall, then coupled with 
glutaraldehyde, and rinsing chitosan again to react with glutaraldehyde. 
The aim of this work was to investigate the eremomycin adsorption and study two types of chitosan-based 
coating (chitosan and coupled chitosan) for eremomycin-mediated enantioseparations. The coupled chitosan 
modification was performed and the convenience of such coating was shown. Basic factors influencing the 
separation of aromatic carboxylic acids were examined, and optimal conditions were chosen. Fast and effective 
enantioseparations of tested compounds were achieved. 
2. Experimental 
2.1. Chemicals and reagents 
Flurbiprofen, fenoprofen, ibuprofen, indoprofen, ketoprofen, mandelic, α-methoxyphenylacetic, 2-
phenoxypropionic, 3-phenylbutyric acids, low molecular weight chitosan (deacetilation degree 75-85%) were 
obtained from Sigma-Aldrich (St. Louis, USA). Glutaric aldehyde (25% solution) was obtained from Merck, 
Germany. Sodium acetate, sodium hydroxide, acetic acid were purchased from Reachem (Moscow, Russia). 
Propanol-2 was HPLC grade (Cryochrom, St. Petersburg, Russia). Eremomycin was supplied by the JSC 
BioChemMack S&T (Moscow, Russia). The purity of the antibiotic was about 95%. 
2.2.  Instrumentation  
CE separations were performed on a Capel-105 (Lumex, St. Petersburg, Russia) equipped with a UV detector. 
Fused-silica capillaries (35 cm (27 cm to the detector window) × 75 µm I.D.) were purchased from Polymicro 
Technologies (Phoenix, USA). All compounds were detected at 230 nm and the cartridge coolant temperature was 
set at 20°C. All samples were introduced using pressure injection (12.5 kPa × s). 
2.3.  Procedure 
Buffer solutions were prepared by mixing 0.1 M acetic acid and sodium acetate solutions, adjusted to the desired 
pH, and then diluted. Buffer solutions were filtered with 0.22 µm membrane filter. The eremomycin stock solutions 
were prepared by dissolving eremomycin in a buffer solution followed by ultrasonic degasation. The eremomycin 
solutions were stored at +4°C when not in use. All chiral analytes (0.5 mg/ml) were dissolved in distilled water. 
Prior any modification capillaries were rinsed with 1M NaOH for 30 min and with deionized water for 15 min. 
Chitosan coating was prepared as described in [12] by washing the pretreated capillary with 0.5% chitosan .Coupled 
chitosan coating was prepared as reported Huang et al. [13]. The capillary was then rinsed with chitosan (1%) for 10 
min, allowed to contact for 10 min, rinsed with 12.5% glutaraldehyde solution (5 min) and contact statically 15 min. 
The chitosan was rinsed for 10 min and contact statically 10 min. The capillaries were purged daily with run buffer 
for 15 min. Between runs, the capillary was rinsed at a high pressure with buffer as specified below. Propanol-2 was 
used as an electroosmotic flow (EOF) marker.  
3. Results and discussion 
3.1. Eremomycin adsorption study 
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As other macrocyclic antibiotics, eremomycin can be positively or negatively charged. In 100 mM phosphate 
buffer, its isoelectric point pI is 7.6. Previously, it has been shown that, due to reduction of the EOF, the presence of 
eremomycin at pH < 7.6 demanded applying a positive pressure (1 kPa) for the analysis [5]. To evaluate the 
adsorption properties of eremomycin on the fused-silica surface, the approach described by Fang et al. [14] was 
used. The mobility-based wall adsorption isotherm, which is the dependence of effective electrophoretic mobility of 
chiral selector on its concentration, was plotted (Fig.1). Effective mobilities were calculated as usual [2]. When 
chiral selector concentration increased, its effective electrophoretic mobility augmented because of the greater 
absorbed amount of positively charged eremomycin. For concentration of eremomycin being higher than 0.8 mM, 
the reversal of the EOF was observed, which was caused by the interaction of the positively charged chiral selector 
molecules with the capillary wall. In this case, the separation in uncoated capillary without external pressure is 
possible if using negative polarity; further experiments are in progress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. The mobility-based wall adsorption isotherm 
of eremomycin. 20 mM acetate buffer (pH 5.5), +25 
kV. 
 
Fig. 2. Effect of eremomycin concentration on 
ketoprofen separations. Run buffer: 20 mM acetate 
buffer (pH 4.5), a) 0.75 mM eremomycin, b) 1.6 mM 
eremomycin, 5×10-3 % chitosan, -10kV. a) Rs = 1.4, 
α =  1.08, N1/m = 43000; b) Rs = 3.1, α = 1.11, N1/m 
= 46000. 
 
3.2. Separation using chitosan coating 
Therefore, to reduce the adsorption the alteration of the capillary wall charge could be useful,  Chitosan (pKa = 
6.5) was suggested for the enantioseparation of basic drugs with methyl-β-CD as a chiral selector at pH 2.8 [12]. 
Such a polycationic polymeric modification changes the wall charge and reverses the EOF. The coating was 
prepared as described above. Unfortunately, injection of eremomycin in acetate buffer (pH 5.5) in the chitosan-
coated capillary led to low reproducibility of the migration times and peak areas. For example, the migration times 
for EOF were 16.8, 20.4, 21.6 and 27.1 minutes upon successive injections. Washing the capillary with run buffer, 
containing 5×10-3 M chitosan, between runs did not increase the reproducibility dramatically. Using run buffer with 
dissolved chitosan (5×10-3 %) did not resulted in increased stability of coating. At pH 5.5, the chitosan charge was 
reduced and some free silanols were present. As a result, eremomycin and chitosan molecules competed to adsorb 
on the wall. No enantioseparation was achieved. 
3.3. Separation using coupled chitosan coating 
Wall modification described in [13] leads to the formation of the coupled chitosan on the capillary wall. It has 
been shown that the coating could be used in the range of pH from 1.8 to 12. The capillaries prepared by the 
procedure above are stable for at least 4 weeks. All further experiments were carried out using the coupled chitosan-
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 coated capillary. In the coated capillary, filled with 20 mM acetate buffer (pH 4.5) containing 0.75 mM 
eremomycin, the migration times were increasing to some degree upon successive injections. In the all the buffers 
used the EOF was reversed, so the negative voltage was applied. To ensure high reproducibility of the migration 
times, 5×10-3 % chitosan was added to the run buffer. The analysis time did not increase significantly and the 
separation selectivity α did not change either.  
The effect of the eremomycin concentration was then investigated by the example of profens. The resolution 
improved upon the increase of the selector concentration from 0.75 to 1.60 mM. The migration times slightly 
increased as well. The eremomycin concentration as low as 0.75 mM was sufficient for baseline separation of 
indoprofen and flurbiprofen, while the resolution factor Rs for ketoprofen was 1.4. Enantioseparations of ketoprofen 
is shown at Fig. 2. It seems that both in presence and in absence of chitosan eremomycin demonstrates the best 
selectivity towards indoprofen and flurbiprofen. The increase of chitosan concentration is illustrated with Fig. 3. 
Although some decrease in analysis time was observed, adding 1×10-2 % of chitosan to the run buffer lead to more 
baseline noise and reduced resolution factor. 
 
 
 
 
Fig. 3. Effect of chitosan concentration on indoprofen 
separations. Run buffer: 20 mM acetate buffer (pH 
4.5), 1.6 mM eremomycin, a) 5×10-3 % chitosan, b) 
1×10-2 %, -10kV. a) Rs = 6.0, α =  1.16, N1/m = 
75000; b) Rs = 4.0, α = 1.13, N1/m = 54000 
.Table 1. Enantioseparations of tested compounds 
in optimum conditions 
 
Compound t
migr.1, min Rs α 
Indoprofena 6.0 6.0 1.16 
Flurbiprofena 4.4 2.6 1.10 
α-methoxyphenylacetic 
acida 4.6 0.8 1.06 
Ibuprofenb 6.1 5.3 1.20 
Fenoprofenb 5.5 1.2 1.05 
3-phenylbutiric acidc 4.9 1.1 1.05 
Ketoprofend 4.9 4.1 1.11 
Mandelic acide 3.8 1.3 1.04 
2-phenylpropionic acide 5.2 0.7 1.10 
Separation conditions: 20 mM acetate buffer, apH 
4.5, 5×10-3% chitosan, 0.75 mM eremomycin; bpH 
6.2, 5×10-3% chitosan 1.6 mM eremomycin; cpH 5.0, 
5×10-3% chitosan, 0.75 mM eremomycin; dpH 5.0, 
5×10-3% chitosan 1.6 mM eremomycin; epH 4.5, 0% 
chitosan, 0.75 mM eremomycin; applied voltage -10 
kV. 
Since eremomycin adsorption was suppressed, more diluted 20 mM run buffers were used. Slightly acidic buffers 
were shown to favor enantioseparations of profens using macrocyclic antibiotics [5,6,15]. Taking into account that 
this class of selectors is unstable a pH < 4, the range of pH 4.5-6.0 was tested. The optimum conditions (pH, 
chitosan concentration, selector concentration) were not the same for all the compounds (see table 1). At pH 6.2, the 
best results were obtained for ibuprofen and fenoprofen, while somewhat increased baseline noise and deformation 
of peak shape were observed for the other compounds.  
Modification of the capillary with coupled chitosan allowed using more diluted run buffer with smaller 
chiral selector concentration. Due to the absence of external pressure resulting in flat flow profile, the calculated 
efficiencies (N/m) are much higher as compared with separation in fused-silica capillary. However, the separation 
selectivity was worse in presence of chitosan. The migration times did not exceed 7 min, which is almost 10 times 
faster than in uncoated capillary. Because of the long-end injection, the achieved separations are not as fast as when 
using vancomycin-based separation in HDB-coated capillary (3-4 minutes) [11].  
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4. Conclusions 
The coupled chitosan coated capillary enabled fast and more efficient enantioseparations of profens and some 
other aromatic carboxylic acids as compared with the conventional fused-silica capillary. A promising way to 
achieve faster separation with better selectivity is the combination of partial filling technique and coupled chitosan 
coating, which is the object of further investigation. 
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